EQT is considering giving shortlisted bidders in the sale process of Ginko China more time to complete due diligence, according to two sources familiar with the matter.

CVC, Primavera Capital and Warburg Pincus are among the finalists in the fray, according to one of the sources and two additional sources familiar with the situation.

The bidders will need to confirm their final bids, said two of the sources, without giving the exact deadline.

The sellside, which is advised by JPMorgan and Goldman Sachs, previously extended the binding round deadline by around two weeks to the end of July, three of the sources and another source familiar with the matter said.

EQT was seeking an enterprise value of at least USD 1.1bn for Ginko China, which generated EBITDA of around USD 50m in 2025 and was projected to deliver EBITDA of USD 60m to USD 70m in 2026, according to Mergermarket’s report in May 2026.

EQT had collected initial bids for Ginko China on 22 May, as per another Mergermarket report in April 2026.

EQT relaunched the sale of Ginko China after its prior deal with Advent International fell through in late 2025, according to this newswire’s report in March 2026.

Established in 1985, Ginko manufactures and sells contact lenses under brands including Hydron and Horien, according to its website.

EQT, CVC, Primavera and Warburg Pincus declined to comment.